Related references
Note: Only part of the references are listed.High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa
Lindiwe Skhosana et al.
PLOS ONE (2015)
Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
Nicholas I. Paton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir
K. Theys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa
Christopher J. Hoffmann et al.
ANTIVIRAL THERAPY (2013)
Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine
Michele W. Tang et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study
LANCET (2013)
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens
Gert U. Van Zyl et al.
PLOS ONE (2013)
High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa
Justen Manasa et al.
PLOS ONE (2013)
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen
Henry Sunpath et al.
AIDS (2012)
Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa
Kim C. E. Sigaloff et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy
Carole L. Wallis et al.
ANTIVIRAL THERAPY (2012)
Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa
Kim C. E. Sigaloff et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa
J. Nomthandazo Dlamini et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment Options
Ashika Singh et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Antiretroviral Resistance Patterns and Factors Associated With Resistance in Adult Patients Failing NNRTI-Based Regimens in the Western Cape, South Africa
Gert U. van Zyl et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1
Dimitrios Coutsinos et al.
PLOS ONE (2011)
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa
Ziad El-Khatib et al.
AIDS (2010)
Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa
Carole L. Wallis et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
FastTree 2-Approximately Maximum-Likelihood Trees for Large Alignments
Morgan N. Price et al.
PLOS ONE (2010)
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa
Christopher J. Hoffmann et al.
CLINICAL INFECTIOUS DISEASES (2009)
FastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix
Morgan N. Price et al.
MOLECULAR BIOLOGY AND EVOLUTION (2009)
Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa
Roos E. Barth et al.
AIDS (2008)
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa
Vincent C. Marconi et al.
CLINICAL INFECTIOUS DISEASES (2008)
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
Bluma G. Brenner et al.
AIDS (2006)
Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation
J Weber et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine
C Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood
S Guindon et al.
SYSTEMATIC BIOLOGY (2003)
Virologic correlates of adherence to antiretroviral medications and therapeutic failure
CF Perno et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity
KL White et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy
V Miller et al.
AIDS (2000)
Share Paper
